Cabotegravir long-acting (CAB-LA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cabotegravir long-acting (CAB-LA), covering 2024-12-13 to 2024-12-13. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetic Interactions of ENG Subdermal Implants with Long-Acting Cabotegravir (CAB-LA) and LA Rilpivirine (RPV-LA) (CARLA) [Phase 4]